/
Food Additives and Contaminants/
EU Regulation 2018/213 Testing for Endocrine Disruptors in PackagingEU Regulation 2018/213 Testing for Endocrine Disruptors in Packaging: A Comprehensive Guide
As a leading laboratory testing service provider, Eurolab offers expert support to ensure compliance with EU Regulation 2018/213 on the testing of endocrine disruptors in packaging. This comprehensive guide provides an in-depth understanding of the regulatory framework, standard requirements, and test conditions for this critical testing service.
STANDARD-RELATED INFORMATION
EU Regulation 2018/213 is based on international standards that govern the testing of endocrine disruptors in packaging. These standards ensure that tests are conducted with accuracy, reliability, and consistency across the European Union. The relevant standards include:
These standards are developed and maintained by international standardization organizations such as ISO, IEC (International Electrotechnical Commission), and CEN (European Committee for Standardization). Standard development is a collaborative effort between industry experts, regulatory bodies, and national standards institutions.
STANDARD REQUIREMENTS AND NEEDS
EU Regulation 2018/213 Testing for Endocrine Disruptors in Packaging is essential to ensure the safety of consumers, protect the environment, and maintain product quality. This testing service helps businesses comply with regulations by detecting potential endocrine disruptors in packaging materials.
The consequences of not performing this test can be severe, including:
Industries that require EU Regulation 2018/213 Testing for Endocrine Disruptors in Packaging include:
The risk factors associated with non-compliance are significant, including:
TEST CONDITIONS AND METHODOLOGY
The testing process involves a series of steps to ensure accuracy, reliability, and consistency. The following is an overview of the test conditions and methodology:
1. Sample Preparation: Packaging materials are collected from production sites or obtained from suppliers.
2. Testing Equipment and Instruments: Specialized equipment such as HPLC (High-Performance Liquid Chromatography), GC-MS (Gas Chromatography-Mass Spectrometry), and ICP-MS (Inductively Coupled Plasma Mass Spectrometry) are used for analysis.
3. Testing Environment Requirements: Temperature, humidity, and pressure conditions are controlled to ensure accurate results.
4. Measurement and Analysis Methods: Samples are analyzed using standardized methods such as ISO 16139:2016 and EN 16555-1:2017.
TEST REPORTING AND DOCUMENTATION
Test reports include detailed information on:
Eurolabs reporting system ensures transparency, accuracy, and compliance with regulatory requirements.
WHY THIS TEST SHOULD BE PERFORMED
Performing EU Regulation 2018/213 Testing for Endocrine Disruptors in Packaging offers numerous benefits:
WHY EUROLAB SHOULD PROVIDE THIS SERVICE
Eurolab offers expert support for EU Regulation 2018/213 Testing for Endocrine Disruptors in Packaging due to:
Eurolabs commitment to quality, accuracy, and customer satisfaction ensures that businesses receive reliable testing services that meet regulatory requirements.
In conclusion, EU Regulation 2018/213 Testing for Endocrine Disruptors in Packaging is essential for ensuring product safety, protecting the environment, and maintaining business reputation. By understanding the standard-related information, standard requirements, and test conditions, companies can make informed decisions about compliance and risk management. Eurolabs expert support ensures that businesses meet regulatory requirements with confidence.
Insert Contact Information
Eurolab: Your Partner for Regulatory Compliance
Contact us to learn more about our EU Regulation 2018/213 Testing for Endocrine Disruptors in Packaging services. Our team is committed to providing accurate, reliable testing solutions to ensure your business meets regulatory requirements.